Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
797 Migraine Headaches
clinical trials

Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Integrative Research Center of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
Pediatric Associates of Charlottesville, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 13839
mi
from
Salisbury, NC
Click here to add this to my saved trials
Musculoskeletal, Neurology, Rheumatology, Orthopedics / Podiatry Clinical Trial
Adverse Events in Dry Needling
Status: Enrolling, Phase
Updated: 12/31/1969
Benchmark Physical Therapy
mi
from
Acworth, GA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Family Medicine Specialists/CIS
mi
from
Wauconda, IL
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
Covington, LA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
OK Clinical Research, LLC
mi
from
Edmond, OK
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Eastside Therapeutic Resource dba Core Clinical Research
mi
from
Everett, WA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
College Park Family Care Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
StudyMetrix Research
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Hillcrest Family Practice
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Sentara Family Medicine Physicians
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Palm Beach Medical Group
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Family Medicine Specialists/CIS
mi
from
Wauconda, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Kapiolani Womens and Childrens Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
CORE (Center for Outpatient Research)
mi
from
Springfield, MO
Click here to add this to my saved trials
Postdural Puncture Headache Clinical Trial
2 Dose Neuraxial Morphine for Prevention of PDPH
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rutgers-Newark
mi
from
Newark, NJ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Brigham Women's Hospital Neurology Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah Primary Care
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Vagus Nerve Stimulation: Treatment for Gulf Veterans With Gulf War Illness
Status: Enrolling
Updated: 12/31/1969
East Orange Veterans Administration Medical Center
mi
from
East Orange, NJ
Click here to add this to my saved trials
Migraine With or Without Aura Clinical Trial
Efficacy, Safety, and Tolerability of Twice Daily Oral ALLOD-2 vs. Placebo in Episodic Migraine Prevention (ANODYNE-3)
Status: Enrolling, Phase II, III
Updated: 3/18/2018
Annette Toledano, M.D.
mi
from
North Miami, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Clinical Research Center (132)
mi
from
Bellevue, WA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Blue Sky Neurology (106)
mi
from
Englewood, CO
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Josephson Wallack Munshower Neurology P.C. (114)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Clinical Research, LLC. (135)
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Biotech Pharmaceutical Group (138)
mi
from
Miami, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Newport Beach Clinical Research Assoicates, Inc. (108)
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Granger Medical Holladay (111)
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Ki Health Partners, LLC dba New England INstitute for Clinical Research (128)
mi
from
Stamford, CT
Click here to add this to my saved trials
Headache, Migraine Clinical Trial
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Status: Enrolling, Phase III
Updated: 3/1/2018
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Post-Traumatic Headache Clinical Trial
A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of PPTH
Status: Enrolling, Phase II
Updated: 12/31/1969
Teva Investigational Site 14057
mi
from
Riverwoods, IL
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Integrative Research Center of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Alexian Brothers Medical Center
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Migraine Clinical Trial
AMG 334 20160172 Pediatric Migraine PK Study.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Migraine Clinical Trial
AMG 334 20160172 Pediatric Migraine PK Study.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Migraine Clinical Trial
AMG 334 20160172 Pediatric Migraine PK Study.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Crescent City Headache and Neurology Center
mi
from
Chalmette, LA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
BTC of Lincoln
mi
from
Lincoln, RI
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
MedPharmics, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Tucson Neuroscience Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Aventura Neurological Associates, PA
mi
from
Aventura, FL
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
BTC of New Bedford
mi
from
New Bedford, MA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Heartland Research Associates, an AMR company
mi
from
Wichita, KS
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
Covington, LA
Click here to add this to my saved trials
Chronic Migraine Clinical Trial
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Neurology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Crescent City Headache and Neurology Center
mi
from
Chalmette, LA
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Children's Mercy Hospital and Clinics
mi
from
Kansas City, KS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
Renown Institution for Neurosciences
mi
from
Reno, NV
Click here to add this to my saved trials
Neurology Clinical Trial
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
Universitair Ziekenhuis Gent
mi
from
Gent,
Click here to add this to my saved trials
Neurology Clinical Trial
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
Status: Enrolling, Phase IV
Updated: 12/31/1969
Rutgers, Robert Wood Johnson Medical School , Pain Center of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver Primary Center
mi
from
Denver, CO
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital Headache Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic in Arizona Headache Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Study MEtrix, LLC
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Dent Neurosciences Research Center (129)
mi
from
Amherst, NY
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Research Center, Inc (134)
mi
from
Anaheim, CA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Neurology, P.A. (110)
mi
from
Dallas, TX
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Axcess Medical Research (126)
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
J. Lewis Research Inc. Foothill Family Clinic (107)
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Clinical Research, LLC (130)
mi
from
Savannah, GA
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Center of NJ (123)
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Headache, Migraine Clinical Trial
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Status: Enrolling, Phase III
Updated: 3/1/2018
Crescent City Headache and Neurology Centre
mi
from
Chalmette, LA
Click here to add this to my saved trials
Headache, Migraine Clinical Trial
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Status: Enrolling, Phase III
Updated: 3/1/2018
Hartford Headache Center
mi
from
East Hartford, CT
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
Direct Helpers Research Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
Acute Migraine With or Without Aura Clinical Trial
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Status: Enrolling, Phase III
Updated: 12/31/1969
NYCT, A member of Alliance, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Neurology Clinical Trial
Topical Bimatoprost in the Treatment of Migraine
Status: Enrolling, Phase II
Updated: 12/31/1969
CTI Clinical Trial and Consulting Services
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Migraine Headache Clinical Trial
Auricular Acupuncture vs SOC in Migraine HA
Status: Enrolling
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Migraine Clinical Trial
AMG 334 20160172 Pediatric Migraine PK Study.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Neurology Clinical Trial
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Status: Enrolling, Phase
Updated: 12/31/1969
Quality Living
mi
from
Omaha, NE
Click here to add this to my saved trials
Migraine Clinical Trial
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Status: Enrolling, Phase II, III
Updated: 12/31/1969
DelRicht Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Discovery Clinical Research
mi
from
Plantation, FL
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Ocean State Clinical Research Partners
mi
from
Lincoln, RI
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Rancho Cucamonga Clinical Trials
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
The Headache Center
mi
from
Ridgeland, MS
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
DelRicht Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hightower Clinical
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Migraine Clinical Trial
Acute Treatment Trial in Adult Subjects With Migraines
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Wilmington Health
mi
from
Wilmington, NC
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling, Phase III
Updated: 5/4/2016
Clinical Research Center of NJ
mi
from
Vorhees, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Alaska Native Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Duke University Medical Center (PICU / NICU)
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling, Phase
Updated: 4/2/2018
Kids Research Institute
mi
from
Randwick,
Click here to add this to my saved trials
Episodic Cluster Headache Clinical Trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Status: Enrolling, Phase III
Updated: 12/31/1969
Teva Investigational Site 13841
mi
from
Richmond, TX
Click here to add this to my saved trials
Episodic Cluster Headache Clinical Trial
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Status: Enrolling, Phase III
Updated: 12/31/1969
Teva Investigational Site 13839
mi
from
Salisbury, NC
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Univerisity of Colorado Denver Headache Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Neurology
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Memorial Healthcare
mi
from
Hollywood, FL
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic in Arizona Neurology Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
The Headache Center
mi
from
Ridgeland, MS
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah Headache Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Migraine Clinical Trial
Status Migrainosus - Differentiating Between Responders and Non-responders
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hartford HealthCare Headache Center
mi
from
Wethersfield, CT
Click here to add this to my saved trials
Cluster Headache Clinical Trial
A Study to Explore the Long-Term Safety of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache
Status: Enrolling, Phase III
Updated: 12/31/1969
Teva Investigational Site 13841
mi
from
Richmond, TX
Click here to add this to my saved trials
1 2 3 4 5 6 7 8